BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 15583806)

  • 1. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
    Worbs S; Shabani N; Mayr D; Gingelmaier A; Makrigiannakis A; Kuhn C; Jeschke U; Kupka MS; Friese K; Mylonas I
    Oncol Rep; 2007 Jan; 17(1):97-104. PubMed ID: 17143484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.
    Mylonas I; Makovitzky J; Fernow A; Richter DU; Jeschke U; Briese V; Gerber B; Friese K
    Arch Gynecol Obstet; 2005 Jun; 272(1):59-66. PubMed ID: 15309402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue.
    Mylonas I; Makovitzky J; Hoeing A; Richter DU; Vogl J; Schulze S; Jeschke U; Briese V; Friese K
    Acta Histochem; 2006; 108(1):1-11. PubMed ID: 16423381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunohistochemical expression of the inhibin/activin subunits is up-regulated by interferon-beta1a in Ishikawa cell line.
    Hoeing A; Kuhn C; Shabani N; Schulze S; Gingelmaier A; Dian D; Jeschke U; Friese K; Mylonas I
    Anticancer Res; 2007; 27(4A):2005-10. PubMed ID: 17649813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibin/activin subunits are immunohistochemically expressed in complete and partial hydatidiform moles.
    Mylonas I; Shabani N; Vogl J; Makovitzky J; Kunze S; Kuhn C; Schulze S; Friese K; Jeschke U
    Anticancer Res; 2007; 27(4A):1995-2000. PubMed ID: 17649811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
    Shim HS; Jung WH; Kim H; Park K; Cho NH
    APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications.
    Mylonas I
    Eur J Cancer; 2010 Sep; 46(13):2485-93. PubMed ID: 20599374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of HPV, steroid receptors (ERalpha, ERbeta, PR-A and PR-B) and inhibin/activin subunits (alpha, betaA and betaB) in adenosquamous endometrial carcinoma.
    Gingelmaier A; Gutsche S; Mylonas I; Shabani N; Kuhn C; Kunze S; Jeschke U; Friese K
    Anticancer Res; 2007; 27(4A):2011-7. PubMed ID: 17649814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of inhibins in the endometrial carcinoma cell line RL-95-2 after stimulation with cortisol and estradiol.
    Vogl J; Höing A; Schulze S; Kuhn C; Wiest I; Shabani N; Jeschke U; Mylonas I; Friese K
    Anticancer Res; 2007; 27(4A):1989-93. PubMed ID: 17649810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin-betaA and -betaB subunits in normal and malignant glandular epithelium of uterine cervix and HeLa cervical cancer cell line.
    Burges A; Shabani N; Brüning A; Mylonas I
    Arch Gynecol Obstet; 2011 Oct; 284(4):981-8. PubMed ID: 21082187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of inhibin/activin subunits alpha (-alpha), betaA (-betaA), and betaB (-betaB) in placental tissue of normal, preeclamptic, and HELLP pregnancies.
    Mylonas I; Schiessl B; Jeschke U; Vogl J; Makrigiannakis A; Kuhn C; Schulze S; Kainer F; Friese K
    Endocr Pathol; 2006; 17(1):19-33. PubMed ID: 16760577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin/activin-alpha, -betaA and -betaB subunits in 302 cases.
    Mylonas I; Worbs S; Shabani N; Kuhn C; Kunze S; Schulze S; Dian D; Gingelmaier A; Schindlbeck C; Brüning A; Sommer H; Jeschke U; Friese K
    Eur J Cancer; 2009 May; 45(7):1304-1314. PubMed ID: 19231155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta A versus beta B: is it merely a matter of expression?
    Thompson TB; Cook RW; Chapman SC; Jardetzky TS; Woodruff TK
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):9-17. PubMed ID: 15451562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.